Evidence map›Paper›PMID 32905080›Full record

ReviewExperimental and therapeutic medicine2020

Utility of indocyanine green injection in patients with cervical cancer besides the identification of sentinel lymph node (Review).

Nicolae Bacalbasa, Irina Balescu, Camelia Diaconu, Carmen Savu, Cornel Savu, Adrian Neacsu, Emil Belu, Ovidiu Bratu, Dragos Cretoiu, Ioana Halmaciu and 5 more

Open access · diamondAbstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Nicolae BacalbasaDepartment of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Irina BalescuDepartment of Surgery, 'Ponderas' Academic Hospital, 021188 Bucharest, Romania.
Camelia DiaconuDepartment of Internal Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Carmen SavuDepartment of Anesthesiology, 'Fundeni' Clinical Institute, 022328 Bucharest, Romania.
Cornel SavuDepartment of Thoracic Surgery, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Adrian NeacsuDepartment of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Emil BeluDepartment of Oncology, 'Al. Trestioreanu' Institute of Oncology, 022328 Bucharest, Romania.
Ovidiu BratuDepartment of Urology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Dragos CretoiuDepartment of Cell and Molecular Biology and Histology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Ioana HalmaciuDepartment of Anatomy, 'George Emil Palade' University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureş, Romania.
Laura IliescuDepartment of Internal Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Cristian BalalauDepartment of Surgery, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Alexandru FilipescuDepartment of Obstetrics and Gynecology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Mihaela VilcuDepartment of Surgery, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Iulian BrezeanDepartment of Surgery, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROInstitutul Clinic Fundeni · ROInstitutul Oncologic Bucuresti · ROUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the wide introduction of screening tests, patients with neoplastic diseases of the uterine cervix trend to be diagnosed in early stages of the disease, and less invasive surgical procedures are needed in certain cases. In this respect, the technique of sentinel lymph node dissection has been widely implemented as part of the therapeutic strategy, indocyanine green (ICG) being one of the most reliable markers for sentinel lymph node detection. However, it seems that this agent is extremely useful in order to achieve better short-term and long-term results after cervical cancer surgery, due to its capacity to determine the uterine vascular perfusion in cases in which conservative treatment, such as trachelectomy, is performed, as well as to prevent and treat lower limb lymphedema. A literature review was conducted of the studies which focused on the role of ICG utility in cervical cancer patients besides sentinel lymph node detection, special focus was given to vascularization preservation and lower limb lymphedema prevention and treatment.

Indexed as

cervical cancerindocyanine greenlower limb lymphedemasentinel lymph nodevascularization

Identifiers

PMID32905080
PMCPMC7464865
OpenAlexW3047511601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.